Belgium's Gimv sells remaining Ablynx stake

BRUSSELS Thu Oct 17, 2013 12:17pm EDT

Related Topics

BRUSSELS (Reuters) - Belgian investment fund Gimv (GIMV.BR) said it sold its remaining stake in biotech firm Ablynx (ABLX.BR) after partnering the company for 12 years.

Gimv said the exit has a positive impact of 3.8 million euros on its last published equity value, and it would use the proceeds to make other investments in the biotech sector.

(Reporting by Robert-Jan Bartunek)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.